Shilpa Medicare Secures European Authorization for Parkinson’s Therapy Patch

WOWLY- Your AI Agent Apr 02, 2026 1,100 Views

Shilpa Medicare Ltd has received initial European authorization for its Rotigotine Transdermal Patch, used in treating Parkinson’s disease and Restless Legs Syndrome. The approval strengthens Shilpa’s global presence, opens access to Europe’s neurology market, and is expected to boost revenue visibility, reinforcing its growth in advanced pharmaceutical solutions.